Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA.
Publié le 09/12/2022
- Blood Adv
- pmid : 36477770
Damaj G, Aubrais R, Bouabdallah K, Chartier L, Herbaux C, Banos A, Brice P, Sibon D, Schiano JM, Cluzeau T, Laribi K, LE Calloch R, Bellal M, Delapierre B, Daguindau N, Amorim S, Agbetiafa K, Chauchet A, Besson C, Durot E, Bonnet C, Fouillet L, Bijou F, Tournilhac O, Gaulard P, Parrens MC
Publié le 17/11/2022
- Nat Commun
- pmid : 36396648
Nore A., Juarez-Martinez A. B., Clement J., Brun C., Diagouraga B., Laroussi H., Grey C., Bourbon H. M., Kadlec J., Robert T., de Massy B.
en savoir plus
Targeting the β(2) -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.
Publié le 18/10/2022
- J Pathol
- pmid : 36245401
Satilmis H, Verheye E, Vlummens P, Oudaert I, Vandewalle N, Fan R, Knight JM, De Beule N, Ates G, Massie A, Moreaux J, Maes A, De Bruyne E, Vanderkerken K, Menu E, Sloan EK, De Veirman K
miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study
Publié le 17/10/2022
- Front Immunol
- pmid : 36325355
Isabelle Duroux-Richard, Anne-Laure Gagez, Elina Alaterre, Rémi Letestu, Olfa Khalifa, Christian Jorgensen, Stéphane Leprêtre, Emmanuelle Tchernonog, Jérôme Moreaux, Guillaume Cartron, Florence Apparailly
Repression and 3D-restructuring resolves regulatory conflicts in evolutionarily rearranged genomes.
Publié le 01/10/2022
- Cell
Ringel AR, Szabo Q, Chiariello AM, Chudzik K, Schöpflin R, Rothe P, Mattei AL, Zehnder T, Harnett D, Laupert V, Bianco S, Hetzel S, Glaser J, Phan MHQ, Schindler M, Ibrahim DM, Paliou C, Esposito A, Prada-Medina CA, Haas SA, Giere P, Vingron M, Wittler L, Meissner A, Nicodemi M, Cavalli G, Bantignies F, Mundlos S, Robson MI
Publié le 26/09/2022
- Current Opinion in Immunology
- pmid : 36174411
van der Horst D, Carter-Timofte ME, van Grevenynghe J, Laguette N, Dinkova-Kostova AT, Olagnier D
en savoir plus
NF90 interacts with components of RISC and modulates association of Ago2 with mRNA.
Publié le 02/09/2022
- BMC Biol
- pmid : 36050755
Grasso G*, Akkawi C*, Franckhauser C, Nait-Saidi R, Bello M, Barbier J, Kiernan R
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma.
Publié le 02/09/2022
- Eur J Haematol
- pmid : 36048142
Daniel A, Ghez D, Ravaiau C, Cavalieri D, Tournilhac O, Herbaux C, Roriz M, Wemeau M, Guillet S, Bossard JB, Hélène D, Kaphan E, Caroline R, Florence L, Pierache A, Michel M, Godeau B, Terriou L
Alternative pathways driven by STING: From innate Immunity to lipid metabolism.
Publié le 01/09/2022
- Cytokine & Growth Factor Reviews
- pmid : 36085258
Vila IK, Guha S, Kalucka J, Olagnier D, Laguette N.
